Tri Locum Partners LP Johnson & Johnson Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $19.7 Million - $21.2 Million	127,362 New	127,362 $21.1 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $13.8 Million - $15.4 Million	-85,596 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $13.2 Million - $14.2 Million	-83,038 Reduced 49.24%	85,596 $14.1 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $918,573 - $1.02 Million	6,001 Added 3.69%	168,634 $27.7 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $22.3 Million - $25.6 Million	162,633 New	162,633 $25.6 Million

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.